Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old
- You have been diagnosed with Crohn's disease according to recognised medical guidelines
- You are currently being treated with a medication called Infliximab
- Your Crohn's disease is currently in an active (flaring) stage, based on specific medical scoring measures (confirm with trial site)
- You are willing to take part in the study and sign a consent form
Who may not be able to join:
- Your liver test results (specifically ALT, AST, or bilirubin levels) are more than twice the normal level
- Your kidneys are not filtering blood well enough, based on a specific kidney function test (confirm with trial site)
- You currently have a serious active infection in your gut or elsewhere that requires antibiotic or antiviral treatment
- You have intestinal tuberculosis, another chronic gut infection, or a cancerous tumour in the intestines
- You are currently pregnant or breastfeeding
- You have diabetes, or your blood sugar levels during screening are above a certain level (fasting blood sugar above 7.0 mmol/L or a blood sugar average test called HbA1c above 6.5%)
- You have a serious mental health condition, or problems with drug or alcohol misuse that would make it difficult to take part in the study
- You have taken part in another clinical trial within the month before joining this study
- The trial team decides that any other health condition or circumstance makes it unsuitable for you to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoyan Wang, MD, The Third Xiangya Hospital of Central South University
Phone: +8613974889301
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Endoscopic remission rate; Clinical remission rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.